Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001415889-17-001421
Filing Date
2017-08-22
Accepted
2017-08-22 16:10:13
Documents
1
Effectiveness Date
2017-08-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9093
  Complete submission text file 0001415889-17-001421.txt   10311
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: D | Act: 33 | File No.: 021-293292 | Film No.: 171045276
SIC: 2834 Pharmaceutical Preparations